community-acquired infections

Mechanisms of Resistance
Comparative Molecular Analysis of Community- or Hospital-Acquired Methicillin-Resistant Staphylococcus aureus
P. D. Fey, B. Saïd-Salim, M. E. Rupp, S. H. Hinrichs, D. J. Boxrud, C. C. Davis, B. N. Kreiswirth, P. M. Schlievert
Letter to the Editor
Moxifloxacin for Community-Acquired Pneumonia
Bart J. A. Rijnders
Clinical Therapeutics
Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment
R. Finch, D. Schürmann, O. Collins, R. Kubin, J. McGivern, H. Bobbaers, J. L. Izquierdo, P. Nikolaides, F. Ogundare, R. Raz, P. Zuck, G. Hoeffken
Mechanisms of Resistance
Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains
Xiao Xue Ma, Teruyo Ito, Chuntima Tiensasitorn, Mantana Jamklang, Piriyaporn Chongtrakool, Susan Boyle-Vavra, Robert S. Daum, Keiichi Hiramatsu
Susceptibility
In Vitro Antibacterial Activities of AF 3013, the Active Metabolite of Prulifloxacin, against Nosocomial and Community Italian Isolates
Maria Pia Montanari, Marina Mingoia, Pietro Emanuele Varaldo
LETTERS TO THE EDITOR
Microbiological Efficacy of Levofloxacin for Treatment of Community-Acquired Pneumonia Due to Chlamydia pneumoniae
Margaret R. Hammerschlag, Patricia M. Roblin
Pharmacology
Trovafloxacin Concentrations in Airway Fluids of Patients with Severe Community-Acquired Pneumonia
R. A. Peleman, V. Van De Velde, P. R. Germonpré, C. Fleurinck, M. T. Rosseel, R. A. Pauwels
Susceptibility
Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
Gary V. Doern, Ronald N. Jones, Michael A. Pfaller, Kari Kugler, The Sentry Participants Group
LETTERS TO THE EDITOR
Cefepime versus Ceftriaxone for Empiric Treatment of Hospitalized Patients with Community-Acquired Pneumonia
Javier Borja, Francesc Jané
Susceptibility
Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
Michael A. Pfaller, Ronald N. Jones, Gary V. Doern, Kari Kugler, The Sentry Participants Group

Pages